Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Medincell's stock fell by 2.91% on Thursday afternoon, closing at 23.32 euros. This decline occurred amidst high volatility, with the stock losing 15.…
Medincell stock falls by 4.25% to €26.58, erasing the week's gains and intensifying a three-month correction. The stock is now close to its 20-day mov…
Montpellier-based biotech Medincell gained 3.11% to €27.20 this Tuesday, January 27 at midday, after closing at €26.38 the previous day. The stock has…
Medincell falls by 8.56% to 26.70 euros on Monday, January 26, 2026, after testing its resistance at 29.20 euros, amid a high RSI at 78 indicating an …
MedinCell's stock closed on Friday at €28.22, marking a weekly increase of 9.98%. This performance significantly outperforms major French market indic…
Oddo BHF ajuste ce vendredi sa position sur Medincell. Le broker modifie son objectif de cours sur la valeur.
Medincell closed with a significant rise on Friday, January 16, 2026. The biotech company from Montpellier gained nearly 5% to 28.22 euros, spurred by…
Medincell advances 3.11% on Wednesday, January 14, 2026, at the opening, reaching 27.18 euros, amid limited trading volumes and anticipation of regula…
The biopharmaceutical group Medincell has announced the publication dates for its financial results for the fiscal year 2025-2026, as well as its gene…
